Mr. Dan Broderick serves as an independent member of Aneurisk’s Board of Directors (Board). Mr. Broderick join the Board in 2025 after supporting Aneurisk as an Entrepreneur in Residence at the University of Pittsburgh, a position he continues to hold. Mr. Broderick provides 38 years of expertise in venture capital, non-dilutive funding, startup operations, and commercial strategy. Prior to his current role at the University of Pittsburgh, Mr. Broderick was Vice President of Investments at BioGenerator, Founder & President of Mid America Healthcare Investors Network, Managing Director at Prolog Ventures, Founder and President of the Global Agtech Investors Network, Member of the board of the National Venture Capital Association, and Managing Director of the Mason Wells Biomedical Fund.